Quick Takeaways
- SILVERARC CAPITAL MANAGEMENT, LLC filed SCHEDULE 13G for Avalo Therapeutics, Inc. Class A Common Stock (AVTX).
- Disclosed ownership: 2.8%.
- Date of event: 31 Dec 2025.
SILVERARC CAPITAL MANAGEMENT, LLC - 31 Dec 2025 SCHEDULE 13G Report for Avalo Therapeutics, Inc. Class A Common Stock (AVTX)
- Filing Manager
- SILVERARC CAPITAL MANAGEMENT, LLC
- Reporting Manager
- SilverArc Capital Management, LLC
- Symbol
- AVTX
- Shares outstanding
- 18,531,307 shares
- Disclosed Ownership
- 524,436 shares
- Ownership
- 2.8%
- Form type
- SCHEDULE 13G
- Filing time
- 10 Feb 2026, 11:36:54 UTC
- Date of event
- 31 Dec 2025
- Previous filing
- 14 Nov 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"SILVERARC CAPITAL MANAGEMENT, LLC disclosed 2.8% ownership in Avalo Therapeutics, Inc. Class A Common Stock (AVTX) on 31 Dec 2025."
What Changed
- Previous schedule filing date: 14 Nov 2025.
- Current filing was accepted on 10 Feb 2026, 11:36.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| SilverArc Capital Management, LLC | 2.8% | 524,436 | 0 | 524,436 | Devesh S. Gandhi | Sole Member of SilverArc Capital Management, LLC | |
| Devesh Gandhi | 2.8% | 524,436 | 0 | 524,436 | Devesh S. Gandhi | Sole Member of SilverArc Capital Management, LLC |